Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
Fulgent Genetics, Inc. (FLGT)
Last fulgent genetics, inc. earnings: 3/10 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.fulgentgenetics.com
Company Research
Source: Yahoo! Finance
Full Year 2023 Core Revenue grows 44% year-over-year to $262.1 million; Q4 2023 Core Revenue grows 21% year-over-year to $66.5 million Ended 2023 with $847.7 million of cash, cash equivalents, and investments in marketable securities, representing cash per share of $28 EL MONTE, Calif., February 28, 2024 BUSINESS WIRE )--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced financial results for its fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Results: Total Revenue of $70.5 million Core Revenue grew 21% year-over-year to $66.5 million GAAP loss of $128.1 million, or $4.30 per share Non-GAAP income of $8.3 million, or $0.28 per share Adjusted EBITDA loss of $6.8 million Cash from operations of $14.9 million Repurchased approximately 873,000 shares of common stock at an aggregate cost of
Show less
Read more
Impact Snapshot
Event Time:
FLGT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FLGT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FLGT alerts
High impacting Fulgent Genetics, Inc. news events
Weekly update
A roundup of the hottest topics
FLGT
News
- Global $5.4 Billion Carrier Screening Market, 2024-2028: Analysis by Product & Service, Type, Technology, Medical Condition, End-user, and Region [Yahoo! Finance]Yahoo! Finance
- Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024Business Wire
- Fulgent Genetics (NASDAQ:FLGT) shareholders have earned a 26% CAGR over the last five years [Yahoo! Finance]Yahoo! Finance
- Fulgent Genetics, Inc. (NASDAQ: FLGT) had its price target lowered by analysts at Piper Sandler from $28.00 to $25.00. They now have a "neutral" rating on the stock.MarketBeat
- An Intrinsic Calculation For Fulgent Genetics, Inc. (NASDAQ:FLGT) Suggests It's 32% Undervalued [Yahoo! Finance]Yahoo! Finance
FLGT
Earnings
- 2/28/24 - Beat
FLGT
Sec Filings
- 4/30/24 - Form 4
- 4/30/24 - Form 4
- 4/30/24 - Form 4
- FLGT's page on the SEC website